⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Product administered at inappropriate site

3,418 total reports1.5% serious outcomes
3,418
Total Reports
5
Deaths
47
Hospitalizations
1.5
Severity Rate
% serious outcomes

About Product administered at inappropriate site Reports

Product administered at inappropriate site has been reported 3,418 times in VAERS from 1990 to 2026.

Of these reports, 5 were associated with death (0.15%) and 47 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Product administered at inappropriate site is 1.5%.

Understanding Product administered at inappropriate site in VAERS

Temporal association only: These reports show Product administered at inappropriate site occurred after vaccination, not necessarily because of vaccination.
Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.
Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.
Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Product administered at inappropriate site. This may reflect usage patterns, not causation.
Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.
Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.